期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
Background: Evidence for the choice of second line, standard vs high dose chemotherapy, (SDCT, HDCT) for patients with relapsed germ cell tumors (GCTs......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 172 ()
The most widespread, malignant, and deadliest type of glial tumor is glioblastoma multiforme (GBM). Despite radiation, chemotherapy, and radical surge......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
This systematic review and meta-analysis evaluated the prognostic role of cell-free DNA (cfDNA) in pancreatic ductal adenocarcinoma (PDAC). Eligible s......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
During the last decade, major improvements have been made in the treatment of renal cell carcinoma (RCC) with the development and use of multiple tyro......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 175 ()
Drug repositioning in cancer has been pursued for years because of slowing drug development, increasing costs, and the availability of drugs licensed ......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()
Examining and addressing unmet care needs is integral to improving the provision and quality of cancer services. This review explored the prevalence o......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncol......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 178 ()
The activation of innate immune response after the engagement of dsDNA is an evolutionarily preserved so-phisticated strategy against invading microbi......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
Introduction: Although salvage surgery (SS) is considered the best curative choice in recurrent head and neck cancer, the identification of patients w......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
Lung cancer organoids (LCOs) have sprung up in more and more researching fields, because of their ability to recapitulate the three-dimensional struct......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior cytotoxic, radiation, or immunosuppressive therapy for an unrelated ......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 173 ()
To summarize randomized controlled trials (RCTs) evidence for the effectiveness of available treatment strategies for elderly patients with glioblasto......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
Acute myelogenous leukemia (AML) is a genetically heterogeneous and aggressive cancer of the Hematopoietic Stem/progenitor cells. It is distinguished ......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()
Statins are commonly prescribed to reduce plasma cholesterol levels and risk of cardiovascular events and mortality. Statin exposure may have cancer-p......
期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
We present the current clinical applications of radiomics in the context of prostate cancer (PCa) management. Several online databases for original ar......